Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?
Purpose: To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. Observations: A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but des...
Main Authors: | Hugo Quiroz-Mercado, Andrés Lisker-Cervantes, Luis Arroyo, Naresh Mandava, Frank S. Siringo, Miguel Paciuc-Beja, Roberto Gonzalez-Salinas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | American Journal of Ophthalmology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993618301476 |
Similar Items
-
A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
by: Dimitrios Karagiannis, et al.
Published: (2008-12-01) -
Large Juxtafoveal Telangiectasia
by: Mohammad Bonyadi, et al.
Published: (2010-01-01) -
Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid
by: Alper Bilgic, et al.
Published: (2021-05-01) -
Iatrogenic choroidal neovascularization associated with subretinal gene therapy surgery
by: Kenneth W. Price, et al.
Published: (2022-09-01) -
Pathogenesis and photocoagulation of subretinal neovascular membranes
by: Morse Pater
Published: (1983-12-01)